Advances in Contraception: IUDs from a Managed Care Perspective
Authors:
- 1 July 2008
- journal article
- Published by SAGE Publications in Journal of Women's Health
- Vol. 17 (6) , 987-992
Abstract
Contraceptive use in the United States is virtually universal among women of reproductive age. However, unplanned pregnancies continue to occur and can be largely attributed to the nonuse and misuse of contraception. Reducing unintended pregnancies constitutes a critical goal for managed care and the public. This can be achieved in part with intrauterine devices (IUDs), which are an effective method of contraception that require a one-time insertion and stay in place for 5-10 years. Therefore, compliance issues are largely mitigated, and actual use efficacy is the same as perfect use efficacy. The IUD is also reversible, unlike tubal ligation, and could potentially be the contraceptive of choice in today's environment. Unfortunately, safety concerns surrounding the use of older IUDs have precluded many women from recognizing the benefits of their use. Currently, the only approved IUDs in the United States are ParaGard, the copper IUD, and Mirena, the levonorgestrel-releasing intrauterine system (LNG-IUS). These devices offer superior safety profiles compared with those products that were withdrawn from the market in the 1970s. In addition to a favorable safety and tolerability profile, the LNG-IUS offers an advantage over copper IUDs, demonstrating improved efficacy in preventing intrauterine and ectopic pregnancies. Successful communication between patients and providers regarding the improved safety and efficacy of newer IUDs will ensure an appropriate place in therapy. Thus, greater numbers of women will recognize the IUD as a safe, cost-effective means to contraception, thereby reducing the economic and social burdens associated with unplanned pregnancies.Keywords
This publication has 29 references indexed in Scilit:
- Long-term use of the levonorgestrel-releasing intrauterine systemContraception, 2007
- Disparities in Rates of Unintended Pregnancy In the United States, 1994 and 2001Perspectives on Sexual and Reproductive Health, 2006
- Contraceptive use and discontinuation: Findings from the contraceptive history, initiation, and choice studyAmerican Journal of Obstetrics and Gynecology, 2006
- Beyond the pill: New data and options in hormonal and intrauterine contraceptionAmerican Journal of Obstetrics and Gynecology, 2005
- U.S. Insurance Coverage of Contraceptives and the Impact Of Contraceptive Coverage MandatesPerspectives on Sexual and Reproductive Health, 2004
- FFPRHC Guidance (January 2004) The Copper Intrauterine Device as Long-term ContraceptionBMJ Sexual & Reproductive Health, 2004
- Pregnancy during the use of levonorgestrel intrauterine systemAmerican Journal of Obstetrics and Gynecology, 2004
- Health effects of long‐termuse of the intrauterine levonorgestrel‐releasing system, A follow‐up study over 12 years of continuous useActa Obstetricia et Gynecologica Scandinavica, 1999
- Medical aspects of oral contraceptive discontinuationAdvances in Contraception, 1992
- Long-term contraception with the levonorgestrel 20 mcg/day (LNg 20) and the Copper T 380Ag intrauterine devices: A five-year randomized studyContraception, 1990